BioXcel Therapeutics (NASDAQ:BTAI) Stock Rating Upgraded by Wall Street Zen
BioXcel Therapeutics (NASDAQ:BTAI – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Friday. BTAI has been the subject of several other reports. RODMAN&RENSHAW raised BioXcel Therapeutics to a “strong-buy” rating in a report on Wednesday, March 19th. Rodman & […]
BioXcel Therapeutics (NASDAQ:BTAI – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Friday. BTAI has been the subject of several other reports. RODMAN&RENSHAW raised BioXcel Therapeutics to a “strong-buy” rating in a report on Wednesday, March 19th. Rodman & […]
